Nefazodone may increase anxiety in panic disorder [4]

Journal of Clinical Psychopharmacology

Volumn 22, Issue 1, 2002, Pages 95-96

  Ströhle, Andreas ^a   Ehrenthal, Hans Dietrich ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; FLUOXETINE; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ANXIETY NEUROSIS; BEHAVIOR THERAPY; CASE REPORT; CLINICAL FEATURE; COGNITIVE THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; PANIC; PRIORITY JOURNAL; TREATMENT PLANNING;

ADULT; ANXIETY; HUMANS; MALE; PANIC DISORDER; TRIAZOLES;

EID: 0036152675     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200202000-00018     Document Type: Letter

References (6)

1. Efficacy of open-label nefazodone treatment in patients with panic disorder
2. Nefazodone and the treatment of panic
3. The jitteriness syndrome in panic disorder treated with antidepressants
4. Serotonin receptors: Subtypes, functional responses, and therapeutic relevance
5. Pharmacology and neuro-chemistry of nefazodone, a novel antidepressant drug
6. Neuroendocrine evidence for serotonin receptors hypersensitivity in panic disorder